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Background: The importance of resting heart rate as a prognostic factor was described in several studies. An
elevated heart rate is an independent risk factor for adverse cardiovascular events and total mortality in patients
with coronary artery disease, chronic heart failure, and the general population. Also heart rate is elevated in the
Multi Organ Dysfunction Syndrome (MODS) and the mortality due to MODS is highly correlated with inadequate
sinus tachycardia.
To evaluate the value of resting heart rate in predicting mortality in patients with traumatic brain injury along
scoring systems like Acute Physiology and Chronic Health Evaluation(APACHE II), Sequential Organ Failure
Assessment (SOFA) and Glasgow Coma Score (GCS).
Method: By analyzing data which was collected from an open labeled randomized clinical trial that compared the
different means of osmotherapy (mannitol vs bolus or infusion hypertonic saline), heart rate, GCS, APACHE II and
SOFA score were measured at baseline and daily for 7 days up to 60 days and the relationship between elevated
heart rate and mortality during the first 7 days and 60th day were assessed.
Results: After adjustments for confounding factors, although there was no difference in mean heart rate between
either groups of alive and expired patients, however, we have found a relative correlation between 60th day
mortality rate and resting heart rate (P=0.07).
Conclusion: Heart rate can be a prognostic factor for estimating mortality rate in brain injury patients along with
APACHE II and SOFA scores in patients with brain injury.
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In critical care units, patients with moderate to severe
brain injury are often intubated and sedated to diminish
the workload of the brain. Agitation or restlessness is
common in these patients and can be associated with
fever, tachycardia, hypertension, and diaphoresis. This
exaggerated stress response, known as sympathetic
storming, occurs in 15% to 33% of patients with severe
traumatic brain injury who are comatose and Glasgow
coma scale is less than 8. Sympathetic storming can* Correspondence: Mojtahed@sina.tums.ac.ir
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distribution, and reproduction in any mediumoccur within the first 24 hours after injury or up to
weeks later [1]. The precise mechanism for the increase
in activity of the sympathetic nervous system is un-
known, but the increased activity is thought to be a stage
of recovery from severe traumatic brain injury [2].
The importance of resting heart rate as a prognostic
factor was described in a retrospective analysis in 1945
[3]. A high heart rate is an independent risk factor for
adverse cardiovascular events and total mortality in
patients with coronary artery disease [4], chronic heart
failure [5], and the general population [6]. Reduction in
heart rate is associated with an improvement in progno-
sis in patients with cardiovascular disease [7].Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Acute Physiology and Chronic Health Evaluation,
Glasgow Coma Scale and Sequential Organ Failure
Assessment data at baseline
Mannitol Bolus of HTS Infusion of HTS P value
Initial GCS 6.10±3.07 8.00±2.23 1.83±6.91 0.06a
Initial SOFA 1.94±6.30 6.27±1.67 7.08±2.53 0.52a
Initial APACHE II 18.70±5.29 18.18±3.48 19.08±5.14 0.68a
LoICU stay(day) 16.9±9 14.2±12 11.17±7.7 0.5a
LoH stay(day) 20.7±21.25 18.18±12.4 18.09±1.84 0.9a
a: One way ANOVA.
* P<0.05 considered significant.
HTS: hypertonic saline, GCS: Glasgow Coma Scale, SOFA: Sequential Organ
Failure Assessment, APACHE II: Acute Physiologic and Chronic Health
Evaluation, LoICU: Length Of Intensive Care Unit, LOH: Length Of Hospital.
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(APACHE II) evaluates cost/benefit of intensive care and
performance of ICU work [8,9] and categorizes patients
or groups of patients according to the severity of their
diseases and also predicts the outcome and response to
therapy and compares patient groups in acutely ill
patients [10].
The sequential organ failure assessment (SOFA) score is
a scoring system to determine the extent of a person's
organ function or the rate of failure in critically ill patients
and to compare patients that would benefit clinical in-
terventions and differentiate the surgical patients who
require either shorter (less than 24 hours) or longer ICU
admission time [11].
The aim of this study is to evaluate the predictive
value of heart rate in traumatic brain injury patients fol-
lowing osmotherapy.
Methods
This study was an open label randomized clinical trial
(clinical registration ID: 201011055107N1) and con-
ducted at Sina trauma center in Tehran (Iran) between
October 2008 and May 2011. The study had received
ethical approval from the ethic committee of Tehran
University of Medical Sciences and health services
(TUMS). Of 33 patients, Group A (n=10) received man-
nitol 20% as a bolus of 1 g/kg, Repeated dosing was
given at 0.25 to 0.5 g/kg as needed, generally every six
hours, Group B (n=11) received 125 cc HTS (Hyper
Tonic Saline) 5% as bolus in 1hour every 6 hour and
Group C (n=12) received 500 cc HTS 5% as infusion
during 24 hours.
For each patient a set of variables included initial
GCS, APACHE II, SOFA scores and heart rate were col-
lected and assessed at baseline and daily during the
course of ICU stay.
Length of ICU and hospital stay, mortality at 7th and
60th days were recorded for all patients for outcome
evaluation. Blood samples were drawn on admission and
first, second and third day.
Statistical analysis
Qualitative variables were recorded by frequency and
percent and compared by Fisher's exact test. Quantita-
tive variables were recorded by Mean ± SD (Standard
Deviation). ANOVA and Kruskal-wallis test were used,
for comparing quantitative variables in three groups,
when was appropriate. For Survival analysis, Kaplan-
Meier method was applied and for comparison between
groups in survival, Log-Rank test was selected. T-test
was conducted to compare mean heart rate, mean APA-
CHE II, mean SOFA and mean GCS after 7 and 60 days
between alive and deceased groups. Regarding variables
like baseline APACHE II, SOFA, GCS scores andbaseline heart rate, Logistic regression was performed to
find correlation between heart rate and 60 days mortal-
ity. P value of less than 0.05 was considered significant.
Results
We assessed 39 consecutive patients with moderate and
severe TBI (Traumatic Brain Injury), 6 of them were in-
eligible. From 33 remaining patients, 10 of them
received mannitol (group A), 11 patients received HTS
as a bolus (group B) and 12 patients as a continuous in-
fusion of HTS (group C).
APACHE II, SOFA and GCS scores at baseline and
also during ICU and hospital stay are shown in Table 1.
Evaluation of 60 days survival between patients (Table 2)
have been demonstrated that there was no significant
difference in 60 days survival of patients for different
treatment groups (P=0.1).
There was a significant correlation between mean
APACHE II, SOFA and GCS scores in treatment groups
(P=0).
There was no significant difference in mean heart rate,
mean APACHE II and SOFA scores between deceased
and alive patients after 7 days (Table 3), but a significant
difference was shown in mean GCS score between these
two groups (P=0.04).
There was a significant difference between expired and
alive patients in mean APACHE II (P=0.005), SOFA
(P=0.006) and GCS scores (P=0.000) after 60 days. Also
baseline heart rate was different between these two
groups (P=0.07) as presented in Table 4 and Figure 1.
Regarding to the performed Logistic regression (base-
line scores and three groups of osmotherapy were
assessed) there was a correlation between baseline heart
rate and 60th day mortality (P=0.07). In the other words
when the Heart Rate were elevated (Table 5), 60 days
mortality was also increased significantly (OR=0.91).
Three means of osmotherapy did not affect 60th day
mortality. We have also found that baseline SOFA and
Table 2 60 days survival of Patients in three groups
Group Survival Mean of survival Std. Error 95% Confidence Interval P value
Mannitol 21% 28.9 8.5 12.06-45.7 0.1
Bolus of HTS 82% 40.2 4.9 30.5-49.9
Infusion of HTS 65.5% 46.8 9.2 28.7-64.8
Overall 48% 41.9 5.9 30.4-53.5
Kaplan-Meier method for Survival analysis and Log-Rank test for comparison between groups.
HTS: Hyper Tonic Saline.
*P<0.05 considered significant.
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mortality (P=0.01 and 0.15 respectively). As a result, by
increasing of SOFA score, 60th day mortality increased
moderately (OR=0.33) and by decreasing of GCS score,
60th day mortality increased significantly (OR=1.93). On
the other hand, heart rate and APACHE II score of 7th day
had correlation with 60th day mortality (P=0.07 and 0.04
respectively) meaning that by increasing of 7th day heart
rate, 60th day mortality increased significantly (OR=0.88)
and when APACHE II score of 7th day increased, 60th day
mortality increased moderately (OR=0.61).Table 3 Correlation between heart rate, acute physiology and
function severity scores and 7th day mortality in dead and al
Heart rate Total Live
Baseline 93.27±17.17 91.35±17.04
The 1st day 94±18.42 93.64±18.78
The 2nd day 90.21±17.01 91.14±17
The 3th day 88.27±15.75 86.89±14.99
The 4th day 89.35±18.23 87.85±17.27
The 5th day 92.41±18.29 91.66±18.12
The 6th day 89.07±16.92 89.03±17.24
The 7th day 87.82±13.14 87.74±13.38
APACHE II
Baseline 17.68±4.58 17.44±4
The 7th day 15.22±4.90 15.26±5
SOFA
Baseline 6.09±2.11 5.92±1.96
The 7th day 5.11±3.14 5.15±3.19
GCS
Baseline 7.43±2.75 7.69±2.76
The 7th day 7.96±3.45 8.50±3.63
Mean heart rate 90.79±14.22 89.90±14.27
Mean APACHE II 16.22±4.61 15.70±3.62
Mean SOFA 5.90±2.31 5.63±2.08
Mean GCS 7.63±2.79 8.03±2.73
APACHE II: Acute Physiologic and Chronic Health Evaluation, SOFA: Sequential Organ
*P<0.05 considered significant.Discussion
Recent studies show that evaluation of APACHE II and
TNF-α in the first day and APACHE II and IL-6 in the
third and seventh days of severe septic patients are inde-
pendent outcome predictors and suggest that IL-6 and
APACHE II are useful cytokine and scoring systems re-
spectively in prediction of mortality and clinical evalu-
ation of these patients [12].
Although reducing heart rate is a therapeutic target to
improve outcomes in cardiovascular patients [13], the
question of transferability to critically ill traumatic brainchronic health evaluation, neurologic and organ
ive groups



















Failure Assessment, GCS: Glasgow Coma Scale.
Table 4 Correlation between heart rate, acute physiology and chronic health evaluation, neurologic and organ
function severity scores and 60th day mortality in dead and alive groups
Heart rate Total Live Dead P value Between alive and dead patients
Baseline 93.27±17.17 89.45±15.41 100.90±18.68 0.07
The 1st day 94±18.42 90.54±16.88 100.90±20.22 0.13
The 2nd day 90.21±17.01 89.86±13.30 90.90±23.53 0.89
The 3th day 88.27±15.75 84.13±9.31 96.54±22.34 0.10
The 4th day 89.35±18.23 86.13±15.17 97.22±23.33 0.12
The 5th day 92.41±18.29 87.38±9.13 105.62±28.71 0.11
The 6th day 89.07±16.92 85.04±9.15 101.14±27.97 0.18
The 7th day 87.82±13.14 85.19±9.24 95.71±19.88 0.20
APACHE II
Baseline 17.68±4.58 16.61±3.51 19.72±5.78 0.06
The 7th day 15.22±4.90 13.80±3.94 19.28±5.40 0.008
SOFA
Baseline 6.09±2.11 5.18±1.33 7.90±2.25 0.002
The 7th day 5.11±3.14 4.15±1.69 7.85±4.67 0.08
GCS
Baseline 7.43±2.75 7.90±2.68 6.33±2.73 0.15
The 7th day 7.96±3.45 8.90±3.66 5.62±0.91 0.001
Mean heart rate 90.79±14.22 87.26±9.41 97.84±19.46 0.11
Mean APACHE II 16.22±4.61 14.68±2.96 19.30±5.84 0.005
Mean SOFA 5.90±2.31 4.93±1.23 7.85±2.77 0.006
Mean GCS 7.63±2.79 8.61±2.80 5.66±1.45 0.000
APACHE II: Acute Physiologic and Chronic Health Evaluation, SOFA: Sequential Organ Failure Assessment,
GCS: Glasgow Coma Scale.
*P<0.05 considered significant.
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result of elevated intracranial pressure, heart rate might
be even lowered than the therapeutic range for instance
in spinal cord injury and neurogenic shock, heart rate
could be less than 60 bpm. The same thing is true for
sever traumatic brain injury where the Glasgow Coma
Score is less than 8 and cerebral perfusion pressure is
below 60 mmHg and intracranial pressure is beyond 20
mmHg. The results of our study have indicated that
there is a correlation between baseline heart rate and
60th day mortality but mean heart rate was not different
between groups of alive and diseased patients. To our
knowledge, this was the first study which was evaluated
the role of a physiological parameter (heart rate) as a
predicting tool for estimating mortality.
There are number of studies which have evaluated the
reliability of different scoring systems in predicting mor-
bidity and mortality in ill patients. Chen et al. had shown
that there was a good correlation between expected
mortality predicted by the APACHE II scoring system
and observed mortality and APACHE II was useful for
evaluating ICU performance and risk stratification [14].
Rehman has demonstrated that this score did not showany correlation between predicted mortality and observed
mortality in critically ill patients but it was useful for
substantial reduction in suffering and cost [15]. In our
study, use of APACHE II score was useful for predicting
prognosis and there was a significant difference in mean
APACHE II score between groups of deceased and alive
patients. Therefore, this scoring system not only allows a
grading of disease severity but also dependably describe
patient prognosis.
Vincent’s study had shown that the SOFA score was a
simple, but effective method to describe organ dysfunc-
tion/failure in critically ill patients and regular, repeated
scoring enables patient condition and disease development
to be monitored and better understood. Also, it may
enable comparison between patients that would benefit
clinical trials [11]. In our study, this score was useful for
evaluating disease development because of significantly
difference in mean SOFA score between diseased and alive
patients.
Ferreira’s study had shown that both mean and highest
SOFA scores were good indicators of prognosis and have
predicted outcome usefully during the first few days of
ICU admission. Independent of the initial score, an
Figure 1 Correlation between elevated baseline heart rate and 60th day mortality. This figure shows that baseline heart rate is different
between these two groups (P=0.07) and is higher in alive group.
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has predicted a mortality rate of at least 50% [16]. In our
study a significant correlation between baseline SOFA
score and 60 days mortality was observed.
Adverse impact of increased heart rate has different
pathophysiological explanations such as increased myo-
cardial oxygen demand and reduced coronary blood flow
due to shortened diastole. Also, it has been shown that
there is an increased disposition to rupture atheroscler-
otic plaques at elevated heart rates [17].
Endotoxin, which is a frequent cause of sepsis and
consecutive MODS and increased in heart failure, dir-
ectly affects the hyperpolarization-activated cyclic nu-
cleotide gated (HCN) channels mediating the pacemakerTable 5 Logistic regression between 60th day mortality
and parameters affecting it in treatment groups
Mortality (60 days) Variable P value OR
Heart rate (Baseline) 0.07 0.91
SOFA (Baseline) 0.01 0.33
GCS (Baseline) 0.15 1.93
Heart rate (the 7th day) 0.07 0.88
APACHE II (the 7th day) 0.04 0.61
APACHE II: Acute Physiologic and Chronic Health Evaluation, SOFA: Sequential
Organ Failure Assessment, GCS: Glasgow Coma Scale.
*P<0.05 considered significant.of human cardiomyocyte [18]. Apart from that, endo-
toxin sensitizes the HCN (Hyperpolarization-activated
Cyclic Nucleotide) channels for sympathetic stimulation
and increasing heart rate. Therefore, endotoxin increases
heart rate and reduces heart rate variability in chronic-
ally instrumented mice and blocking sympathetic and
vagal activity induces bradycardia. Totally endotoxin
induces inadequately high heart rate and narrowed heart
rate variability which causing cardiac and autonomic
dysfunction and indicating poor prognosis in patients
with MODS [13].
Elevation of heart rate leads to increasing of intracra-
nial pressure. Increased intracranial pressure reflects the
presence of mass effect in the brain and is associated
with a poor outcome with acute neurological injury. If
sustained, it has a negative effect on cerebral blood flow
and cerebral perfusion pressure, can cause direct compres-
sion of vital cerebral structures, and can lead to herniation.
The management of the patient with increased intracranial
pressure involves the maintenance of an adequate cerebral
perfusion pressure, prevention of intracranial hypertension,
and optimization of oxygen delivery [19].
If the metabolic demands exceed the supply, cerebral
ischemia will ensue, leading to irreversible neurological
damage [20].
In addition, elevated ICP may intensify the processes
involved in secondary brain injury, negatively affecting
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tension negatively affects morbidity and mortality [20].
Many complications are commonly associated with TBI,
such as deep vein thrombosis (DVT), hyperglycemia, and
excessive protein loss. By promoting optimal ICP (Intra
Cranial Pressure) and CPP (Cerebral Perfusion Pressure)
DVT (Deep Venous Thrombosis) complications, inadequate
nutrition, detrimental hyperglycemia, and seizures in adults
with severe TBI can be prevented [21].
In the multifactor primary prevention trial in GÖteborg,
a clear correlation between resting heart rate and all-
cause-mortality was shown. Compared with individuals
with a heart rate <60 bpm, a heart rate >90 bpm in partici-
pants was associated with a two- to three-fold elevated
mortality [22]. Another trial which followed up patients
with coronary heart disease has shown a significant correl-
ation of elevated heart rate with mortality [4]. In GISSI-2
trial, the heart rate of patients with acute myocardial in-
farction at discharge without atrial fibrillation proved to
be an independent predictor of survival and 6-month mor-
tality was higher for heart rate>100 bpm in compared to
heart rate<60 bpm [23]. In addition to heart rate at base-
line, the mortality rate also depends on the extent of heart
rate reduction by using beta-blocker [7].
In our study, a correlation between elevated baseline
heart rate and 60th day mortality was shown; But this was
not true about 7th day mortality. Mortality in brain injury
is mainly dependent to severity of the injury and elevated
baseline heart rate is also a reflection of disease severity.
The relative correlation between baseline Heart Rate
and 60th day mortality is not observed in last 7 days.
These differences may be a reflection of modifications
by medications or other therapeutic measurements dur-
ing acute phase of treatment.
A fast heart rate on the day of admission was an inde-
pendent and early predictor of death due to MODS in a
prospective, multicenter, observational cohort trial of
high-risk patients with noncardiac surgery [24].
Following cardiac arrest, therapeutic hypothermia by
decreasing heart rate and cathecolamine storm may also
improve neurological recovery [25,26].
Based on the results of the BEAUTIFUL-trial, the
patients with stable coronary heart disease and heart
failure with a heart rate >70 bpm have a worse progno-
sis. Above a heart rate of 65 bpm, every increase in heart
rate of 5 bpm was associated with a higher risk of all-
cause-mortality, hospitalization because of worsening
heart failure, hospitalization because of myocardial in-
farction and hospitalization because of coronary revascu-
larization [27].
Increasing data indicate treatment with beta blockers
might improve survival after traumatic brain injury. The
optimal heart rate range for these patients is unknown.
Admission heart rate in moderate to severe TBI patientswas analyzed to determine if a specific range is asso-
ciated with decreased mortality. After isolated moderate
to severe TBI, HR <50, 50–59, 60–69, and > or =110
were independent predictors of increased mortality com-
pared with HR 80–89. HR outside the range 70–109
could serve as a marker for aggressive resuscitation. As
mortality increased significantly with HR <50, 50–59,
and 60–69, avoiding HR <70 in patients with moderate
to severe TBI recommended [28].
Conclusion
Although, ICU scoring systems like APACHE II and SOFA
are useful tools that are used to quantify severity, estimate
mortality, and allow comparisons among patients, the
experiences of authors in ICU in critically ill patients bring
up some limitations of such score in prediction of out-
come of individual patients [29-32] a notion remaining to
be proved in future by use of a major systematic review
and meta-analysis technique. Resting heart rate is an inde-
pendent predictor of sudden cardiac death and there is a
correlation between heart rate and mortality in critically ill
patients. Baseline heart rate, as a physiological parameter
can predict mortality rate along with scores in patients
with brain injury.
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